10-60177246-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020987.5(ANK3):c.2185-4060G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.195 in 152,090 control chromosomes in the GnomAD database, including 3,391 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.19 ( 3391 hom., cov: 32)
Consequence
ANK3
NM_020987.5 intron
NM_020987.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.301
Publications
6 publications found
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
- intellectual disability-hypotonia-spasticity-sleep disorder syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- intellectual disabilityInheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
- Tourette syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ANK3 | NM_020987.5 | c.2185-4060G>A | intron_variant | Intron 18 of 43 | ENST00000280772.7 | NP_066267.2 | ||
| ANK3 | NM_001204404.2 | c.2134-4060G>A | intron_variant | Intron 18 of 43 | NP_001191333.1 | |||
| ANK3 | NM_001320874.2 | c.2185-4060G>A | intron_variant | Intron 18 of 42 | NP_001307803.1 | |||
| ANK3 | NM_001204403.2 | c.2167-4060G>A | intron_variant | Intron 19 of 43 | NP_001191332.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.195 AC: 29636AN: 151970Hom.: 3390 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
29636
AN:
151970
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.195 AC: 29645AN: 152090Hom.: 3391 Cov.: 32 AF XY: 0.194 AC XY: 14424AN XY: 74366 show subpopulations
GnomAD4 genome
AF:
AC:
29645
AN:
152090
Hom.:
Cov.:
32
AF XY:
AC XY:
14424
AN XY:
74366
show subpopulations
African (AFR)
AF:
AC:
3498
AN:
41518
American (AMR)
AF:
AC:
3335
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
799
AN:
3468
East Asian (EAS)
AF:
AC:
758
AN:
5164
South Asian (SAS)
AF:
AC:
766
AN:
4818
European-Finnish (FIN)
AF:
AC:
2429
AN:
10566
Middle Eastern (MID)
AF:
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17243
AN:
67972
Other (OTH)
AF:
AC:
413
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1195
2390
3585
4780
5975
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
583
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.